Live Longer: Reduction of Calcification in the Arteries with Frequencies

Since 1975 I have been working with some of the leading medical researchers in the world. I worked with twice Nobel Laureate Linus Pauling while a professor at the U.S. Air Force Academy. Working with physicans in the Academy hospital we were contemplating a clinical trial of Vitamin C to see if it reduced colds in cadets. Alas, the administration would not permit it in 1974. However, in 1975 I joined the faculty of the University of Colorado School of Medicine and in 1980 hooked up with Dr. Pauling when he sponsored the University of Colorado Center for Vitamins and Cancer Research (which I co-founded with another senior scientist). I had millions of dollars of grant funding from the National Cancer Center every year for over a decade which got me started on advanced technologies to eliminate disease. A few years ago National Cancer Institute leadership told me I was still on the list of only 300 scientists qualified to lead large grants for cancer research.

—–

Linus Pauling (February 28, 1901 – August 19, 1994) was an American chemist, biochemist, peace activist, author, educator, and husband of American human rights activist Ava Helen Pauling. He published more than 1,200 papers and books, of which about 850 dealt with scientific topics. New Scientist called him one of the 20 greatest scientists of all time, and as of 2000, he was rated the 16th most important scientist in history.

—–

Dr. Pauling showed me his almost complete DNA model and the data he gave Watson and Crick which he claimed enabled them to publish first and achieve a Nobel prize which Dr. Pauling thought rightfully belonged to him. He is the only human to achieve two independent Nobel prizes and was gunning for a third. He radically changed my thinking about medicine by showing me his lab and introducing me to his fellow researchers.

This started me down a path that led to frequency medicine which is now emerging into the mainstream. There are 566 peer reviewed medical research papers at PubMed.gov on Pulsed Electromagnetic Frequency research and 5167 papers published on electromagnetic field therapy. This is truly the future of medicine with FDA approved cancer clinical trials now in progress. Even more interesting is using electromagnetic frequencies to reprogram DNA, a more reliable and accurate approach to CRISPR.

In 2005, I visited another leading medical researcher, Dr. Terry Grossman, also a graduate of the University of Colorado School of Medicine. He had just published a book with Ray Kurzweil, Fantastic Voyage: Live Long Enough to Live Forever. At that time, my biological age was over 20 years younger than my calendar age, almost the lowest he had ever seen (two Japanese guys had me beat).

Dr. Grossman put me on a program to regularly scan my arteries for calcification as he felt was the leading risk of death for someone who had already eliminated some cancers with frequencies (as proven by physician biopsy). I had almost no calcification on a CT scan in 2005. However, by 2012 my calcium score was elevated:

The Coronary Artery Calcium (CAC) Screening Test was done utilizing Ultra-Fast Coaxial Tomography (UF CT Scan) that was able to image the amount of calcified atherosclerotic plaque in the coronary artery walls of your heart. The computer was able to calculate a calcium score for each region of calcified plaque in each coronary artery, and a total calcium score for the heart as a whole.

There are two types of plaque that develop in the arteries: hard or calcified plaque and soft or vulnerable plaque. Heart attack risk appears to be more closely related to soft, vulnerable plaque, but at present we do not have imaging devices able to quantify this type of plaque. The ultrafast CT scan is only able to measure the heart calcified plaque. Since there is a direct correlation between hard, calcified plaque, which your CAC test measured, and soft, vulnerable plaque, higher calcium scores are related to a higher risk of heart attack. Therefore this test offers an indirect assessment of dangerous coronary atherosclerosis. Your ultrafast CT scan of 105 indicated that you had detectable calcified plaque of 105 in your coronary arteries at the 30th percentile.

On 20 December 2016, Dr. Grossman reported: Cardiovascular- Your coronary artery score increased from 15 in 2005 to 105 in 2012, placing you in the 30th percentile at that time. Now your calcium score is 399 at the 65th percentile. Explained the creation of a biofilm that protects self-replicating crystals/nanobacteria.

A new supplement called Nanobac was available at the time and was recommended. A great independently-assessed summary of research is here: Anton Kutikin, PhD in The International Journal of NanoMedicine “The Role of CNPs in Biology & Medicine” www.ncbi.nlm.nih.gov/pmc/articles/PMC3266001

This supplement eliminated some of the nanobacteria and stirred up the rest. When they were active I was able to determine frequencies and target them for elimination. On 13 October 2017, less than a year after my calcium score was 399, I visited Brigham and Women’s state of the art cardiology center in Boston to get a CT scan. Results are below:

My calcium score was 55, a better than 86% reduction. Dr. Grossman said this had never been done before in the history of medicine and results should be followed up with further research studies.

Here is exactly what I did to achieve this result (nothing is guaranteed):

Worked closely with a knowledgable physician to get appropriate lab tests and followup.
Purchased NanobacTX and followed instructions at https://nanobiotechpharma.com/
Used nanobacteria frequency sets at https://www.frequencyfoundation.com/product/nanobacteria/
Purchased frequency application system. For people new to this field try a Spooky2 system of your choice. For those with some expertise consider the Frequency Research Foundation standard lab which is much more powerful for remote work.
Selected the right nanobacteria frequency sets using kinesthiology (muscle testing or a dowsing technique) and ran them while taking the recommended dosage of NanobacTX (initially 8 capsules a day for six months, followed by 2 capsules a day for maintenance).

Biofilms Version 7.0

Biofilms – Version 7.0 is the 1917 release of hundreds of biofilm programs. Thousands of updates and many more bacterial strains have been added. Use of the new Hunter 4025 scanning technology has allowed more precise identification of specific pathogens in some cases.

Most of the 600 strains of periodontal biofilms DNA sequenced by the National Institutes of Health are now in this series of programs. Most strains of lyme disease borrelia are included. Nanobacteria and other biofilms associated with Altzheimers can be found here. Biofilms are associated with all major disease categories. There is even a new program targets abdominal fat.

Recent research has focused on biofilm involvement in tumors. All tumors (benign and malignant) are infected with biofilms. The relationship of causation of tumors by biofilms is still being researched. It appears that many so-called Rife frequencies are really components of biofilms.

There is extensive academic research on biofilms. See Montana State University Center for Biofilm Engineering for the basics, as well as access to papers from dozens of conferences. For example, most people have biofilms forming calcification in their joints and articles. Here is a photo of such a biofilm on a grain of sand:

These biofioms are not doing your heart any good.

Most bacteria infections today are antibiotic resistant biofilms. While over 600 species of these biofilms have been DNA sequenced for periodontal disease, these gum infections are the tip of the iceberg. A huge amount of illness from joint problems to wound infections to heart disease are caused by biofilms.

During the past two years, intensive research at the Frequency Research Foundation has developed frequency sequences for about 400 biofilms. A notable finding is that radical reduction in blood pressure can be achieved by running the appropriate borrelia biofilm programs for infected individuals. All people exposed to lyme disease will need them.

Chronic Periodontitis: Geographic Differences in the Oral Biofilm

January 2005, National Institute of Dental and Craniofacial Research

It has long been assumed that all chronic periodontitis is the same no matter where one lives in the world. But some scientists have wondered whether the bacterial composition of the oral biofilm – the sticky, mat-like microbial communities that form on our teeth and cause chronic periodontitis – might vary geographically. In the November issue of the Journal of Clinical Periodontology, NIDCR grantees and their colleagues report for the first time that this is indeed the case. In a study of more than 300 patients with chronic periodontitis from Sweden, the United States, Brazil, and Chile, they found clear geographical differences in the bacterial content of dental plaque obtained from the periodontal lesions. To hear more about this important paper, the Inside Scoop recently talked with lead author Anne Haffajee, B.D.S., and Sigmund Socransky, D.D.S., the senior author. Both are scientists at The Forsyth Institute in Boston.

—–

Work on biofilms is becoming as extensive as previous work on lyme disease frequencies. Daily updates indicate that they are at the root of much of heart disease, respiratory problems, joint issues, prostate problems, and tumors of all types. Recent releases added many biofilms seen with abnormal cells in cancer patients, raising the question as to whether they are involved in carcinogenesis.

There are over 600 species of periodontal biofilms that have been DNA sequenced. During the past two years, the Frequency Research Foundation has expanded detailed analysis of frequencies for many more biofilm infections. This is the most extensive research effort since development of the lyme disease frequency sets and has involved daily analysis and update of biofilm frequencies from September 2011 until July 2013. As a result these data are the most comprehensive biofilm frequency sets available.

Some are based on the lyme borellia spirochete and cause elevated blood pressure. Others are directly related to mortality from heart disease.

See:

Am J Pathol. 2007 Jan;170(1):33-42.

Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction.

Spagnoli LG, Pucci S, Bonanno E, Cassone A, Sesti F, Ciervo A, Mauriello A.

All biofilms can go systemic in the body and cause a wide variety of symptoms and disease outcomes. For the first time it is possible to work on getting rid of the root cause of gum disease and other persistent infections.

Frequencies are published as a set of over a dozen F165 program files. It is best to work on one biofilm frequency set at a time as one clinician has noted that use of these frequencies is analogous to tearing up the floorboards in your house. You never know what you are going to find underneath.

Biofilm frequencies are available to subscribers.

Nanobacteria Frequencies – always use when doing chelation

Research on nanobacteria has evolved over the last decade. After developing complex frequency sequences for hundreds of biofilms, a number of them are nanobacteria that increase diastolic blood pressure and are directly related to heart disease.

For the first time in over a decade I am publishing frequencies for dozens of the most common nanobacteria strains. Those with the capability of determining what frequencies are needed will find that elevated diastolic blood pressure is associated with these strains. Frequencies are available to subscribers or can be purchased individually. Click here for nanobacteria frequencies …

For diagnostics and remote transmission of frequencies you can sign up for a Photoanalysis.

Are Nanobacteria Making Us Ill?

Amit Asaravala 03.14.05 Wired

Olavi Kajander didn’t mean to discover the mysterious particles that have been called the most primitive organisms on Earth and that could be responsible for a series of painful and sometimes fatal illnesses.

He was simply trying to find out why certain cultures of mammalian cells in his lab would die no matter how carefully he prepared them.

So the Finnish biochemist and his colleagues slipped some of their old cultures under an electron microscope one day in 1988 and took a closer look. That’s when they saw the particles. Like bacteria but an astonishing 100 times smaller, they seemed to be thriving inside the dying cells.

Believing them to be a possible new form of life, Kajander named the particles “nanobacteria,” published a paper outlining his findings and spurred one of the biggest controversies in modern microbiology.

At the heart of the debate is the question of whether nanobacteria could actually be a new form of life. To this day, critics argue that a particle just 20 to 200 nanometers in diameter can’t possibly harbor the components necessary to sustain life. The particles are also incredibly resistant to heat and other methods that would normally kill bacteria, which makes some scientists wonder if they might be an unusual form of crystal rather than organisms…

________

Work at Frequency Foundation has found nanobacteria directly associated with the following:

1. Elevated diastolic blood pressure.
2. Need for excessive sleep. A teenager needed 17 hours of sleep a day returned to normal within one day after applying nanobacteria frequencies.
3. Arthritis – nanobacteria is always associated with the aches and pains in joints, and probably with the deformation associated with neglecting this condition.
4. Artherosclerosis – always check the heart area with the MacArthur BioDisk
5. Immune dysfunction
6. Peanut and other allergies – a researcher in the U.K. had dark field blood microscopy that clearly showed nanobacteria in the blood. She had a life threatening peanut allergy. When the nanobacteria was removed the peanut allergy was almost completely eliminated. She needed no medication after eating peanuts. (Do not try this at home!)
7. Herxheimer effects from chelation therapy – chelation eliminates calcium from the system and releases nanobacteria. Frequencies should always be used in conjunction with chelation therapy.

New supplements for oral chelation using nanotechnology provide results equivalent to IV chelation and Nanobac is particularly effective at eliminating nanobacteria when running frequencies.

British Medical Journal Reports Cholesterol is Not the Issue, Low Saturated Fat is the Problem

OBSERVATIONS

From the Heart

Saturated fat is not the major issue

BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f6340 (Published 22 October 2013)
Cite this as: BMJ 2013;347:f6340
Aseem Malhotra, interventional cardiology specialist registrar, Croydon University Hospital, London
[email protected]
Let’s bust the myth of its role in heart disease
Scientists universally accept that trans fats—found in many fast foods, bakery products, and margarines—increase the risk of cardiovascular disease through inflammatory processes. But “saturated fat” is another story. The mantra that saturated fat must be removed to reduce the risk of cardiovascular disease has dominated dietary advice and guidelines for almost four decades.
Yet scientific evidence shows that this advice has, paradoxically, increased our cardiovascular risks. Furthermore, the government’s obsession with levels of total cholesterol, which has led to the overmedication of millions of people with statins, has diverted our attention from the more egregious risk factor of atherogenic dyslipidaemia.
Saturated fat has been demonised ever since Ancel Keys’s landmark “seven countries” study in 1970. This concluded that a correlation existed between the incidence of coronary heart disease and total cholesterol concentrations, which then correlated with the proportion of energy provided by saturated fat. But correlation is not causation. Nevertheless, we were advised to cut fat intake to 30% of total energy and saturated fat to 10%.” The aspect of dietary saturated fat that is believed to have the greatest influence on cardiovascular risk is elevated concentrations of low density lipoprotein (LDL) cholesterol. Yet the reduction in LDL cholesterol from reducing saturated fat intake seems to be specific to large, buoyant (type A) LDL particles, when in fact it is the small, dense (type B) particles (responsive …
———
As a medical school professor, I never bought in to the low fat myth. After decades of frequency work, I have concluded that my cholesterol which tends to be high is cause by infection induced inflammation by parasites circulating particularly with the swine flu, but even more important by biofilms which start in the gums and then spread throughout the body. The relation of biofilms to heart disease has been reported in a previous blog posting.
The Frequency Research Foundation has developed frequency sequences for almost 400 strains of periodontal biofilms. Over 600 strains have been DNA sequenced at the National Institute of Health. A large number of these strains are borrelia based lyme pathogens found in persons exposed to lyme organisms. These tend to cause high blood pressure as well as elevated cholesterol.

Biofilm Frequencies – Periodontal Disease, Heart Disease, and Other Persistent Infections

[trx_button type=”square” style=”filled” size=”small” align=”left” link=”https://www.frequencyfoundation.com/2017/01/12/biofilms/” popup=”no” top=”inherit” bottom=”inherit” left=”inherit” right=”inherit”]Biofilm Frequencies – thousands of updates[/trx_button]

These biofioms are not doing your heart any good.

Chronic Periodontitis: Geographic Differences in the Oral Biofilm

January 2005

It has long been assumed that all chronic periodontitis is the same no matter where one lives in the world. But some scientists have wondered whether the bacterial composition of the oral biofilm – the sticky, mat-like microbial communities that form on our teeth and cause chronic periodontitis – might vary geographically. In the November issue of the Journal of Clinical Periodontology, NIDCR grantees and their colleagues report for the first time that this is indeed the case. In a study of more than 300 patients with chronic periodontitis from Sweden, the United States, Brazil, and Chile, they found clear geographical differences in the bacterial content of dental plaque obtained from the periodontal lesions. To hear more about this important paper, the Inside Scoop recently talked with lead author Anne Haffajee, B.D.S., and Sigmund Socransky, D.D.S., the senior author. Both are scientists at The Forsyth Institute in Boston.

—–

There are over 600 species of periodontal biofilms that have been DNA sequenced. During the past two years, the Frequency Research Foundation has done detailed analysis of frequencies for over 300 biofilm infections. This is the most extensive research effort since development of the lyme disease frequency sets and has involved daily analysis and update of biofilm frequencies from September 2011 until July 2013. As a result these data are the most comprehensive biofilm frequency sets available.

Some are based on the lyme borellia spirochete and cause elevated blood pressure. Others are directly related to mortality from heart disease. See:

Am J Pathol. 2007 Jan;170(1):33-42.

Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction.

Spagnoli LG, Pucci S, Bonanno E, Cassone A, Sesti F, Ciervo A, Mauriello A.

Frequencies are published as a set of over a dozen F165 program files. It is best to work on one biofilm frequency set at a time as one clinician has noted that use of these frequencies is analagous to tearing up the floorboards in your house. You never know what you are going to find underneath.

Frequencies are available to subscribers for research purposes at subscribers.frequencyfoundation.com.